Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

5.41
-0.0800-1.46%
Post-market: 5.410.00000.00%18:39 EDT
Volume:2.07M
Turnover:11.26M
Market Cap:747.87M
PE:-1.28
High:5.62
Open:5.56
Low:5.31
Close:5.49
Loading ...
Apr 07, 2022

Major Issues Report

8-K - Current report
Apr 05, 2022

Major Issues Report

8-K - Current report
Mar 25, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 22, 2021

Major Issues Report

8-K - Current report
Nov 04, 2021

Major Issues Report

8-K - Current report
Nov 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 29, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 28, 2021

Major Issues Report

8-K - Current report
May 27, 2021

Major Issues Report

8-K - Current report